Bridgeway Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3,557
| Closed | -$32.5K | – | 1438 |
|
2023
Q3 | $32.5K | Sell |
3,557
-3,333
| -48% | -$30.5K | ﹤0.01% | 1328 |
|
2023
Q2 | $146K | Buy |
6,890
+3,333
| +94% | +$70.4K | ﹤0.01% | 1196 |
|
2023
Q1 | $95.7K | Buy |
+3,557
| New | +$95.7K | ﹤0.01% | 1248 |
|
2022
Q3 | – | Sell |
-1,130
| Closed | -$214K | – | 1463 |
|
2022
Q2 | $214K | Sell |
1,130
-2,000
| -64% | -$379K | ﹤0.01% | 1080 |
|
2022
Q1 | $779K | Sell |
3,130
-1,167
| -27% | -$290K | 0.02% | 835 |
|
2021
Q4 | $669K | Hold |
4,297
| – | – | 0.01% | 902 |
|
2021
Q3 | $861K | Hold |
4,297
| – | – | 0.02% | 868 |
|
2021
Q2 | $1.1M | Buy |
+4,297
| New | +$1.1M | 0.02% | 828 |
|
2020
Q1 | – | Sell |
-3,117
| Closed | -$1.39M | – | 1374 |
|
2019
Q4 | $1.39M | Hold |
3,117
| – | – | 0.02% | 654 |
|
2019
Q3 | $958K | Hold |
3,117
| – | – | 0.01% | 735 |
|
2019
Q2 | $991K | Hold |
3,117
| – | – | 0.01% | 739 |
|
2019
Q1 | $1.31M | Hold |
3,117
| – | – | 0.02% | 665 |
|
2018
Q4 | $950K | Hold |
3,117
| – | – | 0.01% | 751 |
|
2018
Q3 | $1.12M | Hold |
3,117
| – | – | 0.01% | 836 |
|
2018
Q2 | $1.14M | Hold |
3,117
| – | – | 0.01% | 828 |
|
2018
Q1 | $921K | Buy |
3,117
+784
| +34% | +$232K | 0.01% | 882 |
|
2017
Q4 | $977K | Hold |
2,333
| – | – | 0.01% | 851 |
|
2017
Q3 | $770K | Hold |
2,333
| – | – | 0.01% | 942 |
|
2017
Q2 | $553K | Buy |
2,333
+1,333
| +133% | +$316K | 0.01% | 1053 |
|
2017
Q1 | $344K | Sell |
1,000
-189
| -16% | -$65K | ﹤0.01% | 1179 |
|
2016
Q4 | $416K | Hold |
1,189
| – | – | 0.01% | 1143 |
|
2016
Q3 | $478K | Buy |
1,189
+659
| +124% | +$265K | 0.01% | 1119 |
|
2016
Q2 | $315K | Buy |
+530
| New | +$315K | ﹤0.01% | 1210 |
|
2015
Q4 | – | Sell |
-58
| Closed | -$27K | – | 1504 |
|
2015
Q3 | $27K | Sell |
58
-416
| -88% | -$194K | ﹤0.01% | 1450 |
|
2015
Q2 | $269K | Buy |
474
+350
| +282% | +$199K | 0.01% | 1281 |
|
2015
Q1 | $1.06M | Hold |
124
| – | – | 0.02% | 767 |
|
2014
Q4 | $1.09M | Hold |
124
| – | – | 0.02% | 733 |
|
2014
Q3 | $585K | Buy |
+124
| New | +$585K | 0.01% | 1001 |
|